Pendrin inhibitor ARBM-201 reduces lung injury in acute respiratory distress syndrome model May 30, 2022 No Comments
ILDONG Pharmaceutical synthesizes new CFTR modulators and/or PDE4 inhibitors May 18, 2022 No Comments
AstraZeneca selects IPF target under drug discovery collaboration with BenevolentAI May 17, 2022 No Comments
ALTA-2530 shows preclinical efficacy as potential treatment of bronchiolitis obliterans syndrome May 5, 2022 No Comments
RSS